01873.HK
Viva Biotech Holdings
HKSE · Healthcare · Biotechnology · CN
HKD 1.34
−2.20%Margins
Gross margin
36.0%
EBITDA margin
21.7%
EBIT margin
11.1%
Net margin
9.4%
FCF margin
13.4%
8.8%
Return on equity
5.1%
Return on assets
8.5%
Return on invested capital
0.53x
Asset turnover
HKD 907.7M
Cash from operations
HKD 0.58
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026